VP, Value Chain Management for Johnson & Johnson comments on various problematic supply chain scenarios and how to overcome them.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Wayne Rothman, VP, Value Chain Management, discusses potential problematic supply chain scenarios that can arise and how to address them.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.